To further assess the clinical value of ABCA6, ABCB11, ABCC6, and ABCG5 in patients with HCC, we re-analyzed the public datasets and focused on early-stage HCC (TNM stage I & II). The gene discussed is ABCB11; the disease is hepatocellular carcinoma.